MedTrace Logo

Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate

NCT03460873 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 432

Last updated 2019-12-02

No results posted yet for this study

Summary

Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate

Conditions

  • Benign Prostatic Hyperplasia (BPH)

Interventions

PROCEDURE

holmium laser enucleation of the prostate

undergo holmium laser enucleation of the prostate

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2019-11-07
Completion
2019-11-28

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03460873 on ClinicalTrials.gov